The International Society for Stem Cell Research group is concerned about clinics that promise results to patients and underestimate the risks of these new treatments. The new guidelines establish standards that can be used to evaluate claims made by these clinics and whether their treatments were developed responsibly. They also insist clinics accurately report their clinical trial results.
